Literature DB >> 4278033

Coagulation abnormalities in patients with inoperable lung cancer.

A B Hagedorn, E J Bowie, L R Elveback, C A Owen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4278033

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  9 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Digital gangrene in small cell lung cancer: response to aspirin treatment.

Authors:  J E Arrowsmith; M A Woodhead; D H Bevan; E M Nanson; A R Cummin
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

3.  Haemostatic abnormalities in brain tumours.

Authors:  V P Singh; D Jain; R Mohan; R Bhatia; M Bhargava
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

4.  Elevated thrombin-antithrombin III complex concentrations in patients with gynaecological malignancy.

Authors:  G Tatra; A Reinthaller
Journal:  Klin Wochenschr       Date:  1991-02-06

5.  Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane or estramustine-17-phosphate.

Authors:  M Blombäck; F Edsmyr; C Kockum; C Paul
Journal:  Urol Res       Date:  1978

6.  Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.

Authors:  B Kemkes-Matthes; H Bleyl
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

Review 7.  Perioperative care of the oncology patient.

Authors:  C J Kelly; J M Daly
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

Review 8.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Pulmonary embolism as the initial manifestation of large cell lung cancer--a case report with review.

Authors:  J K Kim; S M Lee; H T Kim; S Uh; Y Chung; Y H Kim; C Park; S Y Jin; D H Lee
Journal:  Korean J Intern Med       Date:  1992-07       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.